International Symposium on Reverse Cholesterol Transport. Report on a meeting.

The purpose of this symposium was to provide a forum for the reporting of recent findings and the exchange of ideas concerning reverse cholesterol transport, an area of intense interest and some controversy. Data from epidemiological studies have consistently shown that elevated levels of high densi...

Full description

Bibliographic Details
Main Authors: AG Lacko, PH Pritchard
Format: Article
Language:English
Published: Elsevier 1990-12-01
Series:Journal of Lipid Research
Online Access:http://www.sciencedirect.com/science/article/pii/S0022227520421182
id doaj-c7157aacf8df431d85a6201392af1c46
record_format Article
spelling doaj-c7157aacf8df431d85a6201392af1c462021-04-25T04:21:53ZengElsevierJournal of Lipid Research0022-22751990-12-01311222952299International Symposium on Reverse Cholesterol Transport. Report on a meeting.AG Lacko0PH Pritchard1Texas College of Osteopathic Medicine, University of North Texas.Texas College of Osteopathic Medicine, University of North Texas.The purpose of this symposium was to provide a forum for the reporting of recent findings and the exchange of ideas concerning reverse cholesterol transport, an area of intense interest and some controversy. Data from epidemiological studies have consistently shown that elevated levels of high density lipoproteins (HDL) are an index of increased protection against coronary heart disease. However, the mechanism whereby HDL is involved in the prevention and/or reversal of atherosclerosis is unknown. According to one of the hypotheses, HDL acts as the primary acceptor of unesterified cholesterol from cells and functions jointly with the enzyme lecithin:cholesterol acyltransferase (LCAT) and the cholesteryl ester transfer protein (CETP) to facilitate the movement of cholesterol from peripheral tissues to the plasma and ultimately to the liver. Although this mechanism as originally proposed by Glomset is an essential physiological mechanism, the clinical significance of this hypothesis remains unsubstantiated. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, a conference involving the leading investigators of the field, where extensive discussion of the findings and ideas is allowed, appeared highly desirable. Indeed, from the distance of nearly 4 months, feedback from the participants indicates that the meeting was highly successful and the organizers feel that all the projected goals of the symposium were accomplished.http://www.sciencedirect.com/science/article/pii/S0022227520421182
collection DOAJ
language English
format Article
sources DOAJ
author AG Lacko
PH Pritchard
spellingShingle AG Lacko
PH Pritchard
International Symposium on Reverse Cholesterol Transport. Report on a meeting.
Journal of Lipid Research
author_facet AG Lacko
PH Pritchard
author_sort AG Lacko
title International Symposium on Reverse Cholesterol Transport. Report on a meeting.
title_short International Symposium on Reverse Cholesterol Transport. Report on a meeting.
title_full International Symposium on Reverse Cholesterol Transport. Report on a meeting.
title_fullStr International Symposium on Reverse Cholesterol Transport. Report on a meeting.
title_full_unstemmed International Symposium on Reverse Cholesterol Transport. Report on a meeting.
title_sort international symposium on reverse cholesterol transport. report on a meeting.
publisher Elsevier
series Journal of Lipid Research
issn 0022-2275
publishDate 1990-12-01
description The purpose of this symposium was to provide a forum for the reporting of recent findings and the exchange of ideas concerning reverse cholesterol transport, an area of intense interest and some controversy. Data from epidemiological studies have consistently shown that elevated levels of high density lipoproteins (HDL) are an index of increased protection against coronary heart disease. However, the mechanism whereby HDL is involved in the prevention and/or reversal of atherosclerosis is unknown. According to one of the hypotheses, HDL acts as the primary acceptor of unesterified cholesterol from cells and functions jointly with the enzyme lecithin:cholesterol acyltransferase (LCAT) and the cholesteryl ester transfer protein (CETP) to facilitate the movement of cholesterol from peripheral tissues to the plasma and ultimately to the liver. Although this mechanism as originally proposed by Glomset is an essential physiological mechanism, the clinical significance of this hypothesis remains unsubstantiated. Key elements of knowledge are lacking that would allow the linking of cholesterol efflux from cells and tissues with specific events in HDL metabolism, particularly those that are relevant to the prevention and/or reversal of atherosclerosis. Because of the intricate nature of the interaction between the components of reverse cholesterol transport, a conference involving the leading investigators of the field, where extensive discussion of the findings and ideas is allowed, appeared highly desirable. Indeed, from the distance of nearly 4 months, feedback from the participants indicates that the meeting was highly successful and the organizers feel that all the projected goals of the symposium were accomplished.
url http://www.sciencedirect.com/science/article/pii/S0022227520421182
work_keys_str_mv AT aglacko internationalsymposiumonreversecholesteroltransportreportonameeting
AT phpritchard internationalsymposiumonreversecholesteroltransportreportonameeting
_version_ 1721510371130343424